{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:51:41Z","timestamp":1761918701128},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2005]]},"DOI":"10.2169\/internalmedicine.44.114","type":"journal-article","created":{"date-parts":[[2005,3,7]],"date-time":"2005-03-07T06:04:44Z","timestamp":1110175484000},"page":"114-119","source":"Crossref","is-referenced-by-count":11,"title":["Malignant Gastrointestinal Stromal Tumor of the Small Intestine Complicated with Pulmonary Tuberculosis during Treatment with Imatinib Mesylate"],"prefix":"10.2169","volume":"44","author":[{"given":"Mototsugu","family":"TAKASHIMA","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Takasago Municipal Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"IGAKI","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Takasago Municipal Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomokazu","family":"MATSUDA","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Takasago Municipal Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minako","family":"OHYAMA","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Takasago Municipal Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suirin","family":"KANDA","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Takasago Municipal Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"TAMADA","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Takasago Municipal Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"GOTO","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Takasago Municipal Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1007\/s004280000338"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2001.25484"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1159\/000074470"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: Recent advances in understanding of their biology. Hum Pathol <B>30<\/B>: 1213-1220, 1999.","DOI":"10.1016\/S0046-8177(99)90040-0"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2002.124122"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104053441404"},{"key":"7","unstructured":"7) Eisenberg BL. Imatinib mesylate: a molecularly targeted therapy for gastrointestinal stromal tumors. Oncology (Huntingt) <B>17<\/B>: 1615-1626, 2003."},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(01)00028-5"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Demetri GD. Targeting c-kit mutations in solid tumors: Scientific rationale and novel therapeutic options. Semin Oncol <B>28<\/B>: 19-26, 2001.","DOI":"10.1016\/S0093-7754(01)90099-5"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601507"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2003.08.023"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science <B>279<\/B>: 577-580, 1998.","DOI":"10.1126\/science.279.5350.577"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Bauer S, Corless CL, Heinrich MC, et al. Response to imatinib mesylate of a gastrointestinal stromal tumor with very low expression of KIT. Cancer Chemother Pharmacol <B>51<\/B>: 261-265, 2003.","DOI":"10.1007\/s00280-002-0564-x"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.021238"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Singer S, Rubin BP, Lux ML, et al. Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. J Clin Oncol <B>15<\/B>: 3898-3905, 2002.","DOI":"10.1200\/JCO.2002.03.095"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2002.123545"},{"issue":"17","key":"17","first-page":"4297","volume":"59","author":"TANIGUCHI M","year":"1999","ISSN":"http:\/\/id.crossref.org\/issn\/0008-5472","issn-type":"print"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.190"},{"key":"19","unstructured":"19) Rutkowski P, Nyckowski P, Grzesiakowska U, et al. The clinical characteristics and the role of surgery and imatinib treatment in patients with liver metatases from c-Kit positive gastrointestinal stromal tumors (GIST). Neoplasma <B>50<\/B>: 438-442, 2003."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/2\/44_2_114\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:23:06Z","timestamp":1621444986000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/2\/44_2_114\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.44.114","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005]]}}}